Related Experiment Videos

Pericardium-covered stent for septal myocardial ablation in hypertrophic obstructive cardiomyopathy

J Gaspar1, M A Martínez-Ríos, C Vonderwalde

  • 1Department of Interventional Cardiology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico. jgaspar@mail.internet.com.mx

Insights

A novel stent procedure successfully treated severe hypertrophic obstructive cardiomyopathy (HOCM). This minimally invasive technique reduced the left ventricular outflow tract gradient, improving the patient's functional class.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Device Technology

Background:

  • Hypertrophic obstructive cardiomyopathy (HOCM) is a significant cause of heart failure.
  • Severe HOCM can lead to debilitating symptoms and reduced quality of life.
  • Current treatments for HOCM have limitations and potential complications.

Observation:

  • A patient presented with severe HOCM, classified as New York Heart Association functional class III.
  • The patient exhibited a significant left ventricular outflow tract (LVOT) gradient.
  • Standard medical and surgical options were considered.

Findings:

  • A novel interventional approach was employed using a pericardium-covered stent.
  • Selective occlusion of three septal arteries targeting the LVOT gradient was performed.
  • Complete reduction of the LVOT gradient was achieved post-procedure.

Implications:

  • This case demonstrates the potential efficacy of targeted septal artery occlusion with a novel stent for HOCM.
  • The procedure resulted in a significant clinical improvement, with the patient progressing to functional class I.
  • This approach may offer a less invasive alternative for managing severe HOCM, warranting further investigation.

Related Concept Videos